The latest closing stock price for Champions Oncology as of March 07, 2025 is 9.94.
An investor who bought $1,000 worth of Champions Oncology stock at the IPO in 2015 would have $729 today, roughly 1 times their original investment - a 5.63% compound annual growth rate over 10 years.
The all-time high Champions Oncology stock closing price was 17.47 on September 28, 2018.
The Champions Oncology 52-week high stock price is 11.99, which is 20.6% above the current share price.
The Champions Oncology 52-week low stock price is 3.60, which is 63.8% below the current share price.
The average Champions Oncology stock price for the last 52 weeks is 5.86.
An investor who bought $1,000 worth of Champions Oncology stock at the IPO in 2015 would have $729 today, roughly 1 times their original investment - a 5.63% compound annual growth rate over 10 years.
The all-time high Champions Oncology stock closing price was 17.47 on September 28, 2018.
The Champions Oncology 52-week high stock price is 11.99, which is 20.6% above the current share price.
The Champions Oncology 52-week low stock price is 3.60, which is 63.8% below the current share price.
The average Champions Oncology stock price for the last 52 weeks is 5.86.